Should You Take Prescription (“Pharmaceutical

New Post Public Reply Private Reply Replies (4) Message Board
Bhawks wowhappens28 #15316
282


Quote:
Should You Take Prescription (“Pharmaceutical Grade”) Fish Oil?

September 27, 2015 7 Comments


Avid readers of the skeptical cardiologist know that he is not an advocate of fish oil supplements.

One of my first posts (1/2013) was devoted to taking down the mammoth OTC fish oil industry because recent scientific evidence was clearly showing no benefit for fish oil pills.

https://theskepticalcardiologist.com/tag/vascepa/


I'm going to stick with.............

Quote:
•Calamari Oil: A great source of omega-3s is from calamari (squid). It’s naturally high in DHA and is sustainably sourced from squid in deep ocean waters. Plus, the squid are harvested small and only live up to 450 days, so they are clean. Another benefit: Calamari oil doesn’t cause “fishy burps,” or “repeating,” like fish oil can.





Quote:
With so many omega-3 supplements out there, I’m often asked which is the best source of omega-3s—fish, krill, or calamari oil?

At the beginning of my career, I was partial to fish oil. That’s because it could deliver a concentrated source of omega-3s—one that’s far greater than you could get from eating fish.

https://www.drsinatra.com/fish-krill-or-calam...3-benefits

But the newest research shows it’s not enough to just get omega-3s—you need the right type. There are two types of omega-3s that play major roles in good health: docosahexaenoic acid (DHA) and eicosatetraenoic acid (EPA). And studies show DHA omega-3s are the most important for your heart, brain, and eyes.

Yet, the average American gets only about 120 mg of DHA per day. In other countries, like Japan, the average DHA intake is 600 mg per day—which researchers theorize helps to contribute to the good heart health experienced by many people in Japan.

Why Your Body Need DHA Omega-3s

Studies show that DHA omega-3s are vital to every cell and system in your body.

•Blood Pressure Support: DHA fats have a more profound effect on normal blood pressure levels than EPA fats.1
•Arterial Health: In a study of postmenopausal women, those with the highest levels of DHA had better coronary artery health.2
•Circulation: In research, DHA did a better job than EPA in improving vasodilation and endothelial function.3
•Mental Processing: In a nine-year study, DHA was correlated with better brain function and cognitive health.4
•Eye Support: Your eyes need DHA, too. It makes up 30% to 40% of the fatty acids found in the photoreceptors in your eyes, so DHA is critical to your eye health. Plus, research shows omega-3 fatty acids help with natural tear production, keeping your eyes moist and hydrated.5

As essential as omega-3s are for your health, your body can’t manufacture them. So, you need to get them through foods or supplements that are high in DHA omega-3s. This is important because while your body can easily convert DHA to EPA, it has great difficulty converting EPA to DHA.

What Are the Best Sources of DHA Omega-3s?

Fatty fishes can be good sources of DHA omega-3s, including wild caught salmon, herring, small Atlantic halibut, and mackerel. Another good source is DHA enriched eggs.

But it’s tough to get all of the omega-3s you need from food sources alone, so I recommend taking a good omega-3 supplement as well.

With any omega-3 supplement, you want to check the label to see how much DHA and EPA you’re getting. The amount of DHA vs. EPA in a supplement is dependent on the source of the omega-3s.

Fish, Krill, or Calamari: Which Is Higher in DHA?

•Fish Oil: In general, fish oil is a good source of omega-3s—but they generally contain twice as much EPA as DHA. Plus, many people experience “fishy burps” or “repeating” after taking fish oil. That’s because fish oil can be tough to digest.

If you take fish oil, have it with a meal since food will make it less upsetting to your digestive system. It’s also important to make sure the fish oil you’re taking is in softgels, and not liquid, which can oxidize. Taking oxidized fish oil is as bad as eating trans-fatty acids—it can cause serious heart damage.

•Krill Oil: Krill oil, which comes from small shrimp-like crustaceans, contains a phospholipid form of omega-3s that doesn’t have the same “fishy burp” issue as fish oil. Yet, like fish oil, krill supplements tend to contain far more EPA than DHA and I haven’t been impressed with the bioavailability.

•Calamari Oil: A great source of omega-3s is from calamari (squid). It’s naturally high in DHA and is sustainably sourced from squid in deep ocean waters. Plus, the squid are harvested small and only live up to 450 days, so they are clean. Another benefit: Calamari oil doesn’t cause “fishy burps,” or “repeating,” like fish oil can.

How Many Omega-3s Do You Need?

I’ve always recommended 1-2 grams of natural omega-3 supplements a day to get the full benefits. And a recent study leads me to believe that up to 4 grams may be the best dosage to prevent heart attacks.

You want to strive to get that amount through a combination of foods and supplements, preferably ones that are high in DHA omega-3s.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 380

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 283

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 284

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 56

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 460

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 220

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 226

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 423

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 448

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 301

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading

Top 5 Most Recently Viewed Articles

Viasat's Commitment to Shareholders and Future Growth Strategies

Updated Category News Views 168

Viasat's Commitment to Shareholders Viasat, Inc. (NASDAQ: VSAT), a renowned leader in satellite communications, has emphasized its dedication to engaging constructively with shareholders. Recently, the company addressed feedback from Carronade Capital Management, reaffirming its mission to maximize shareholder value. Engaging Constructively with Stakeholders In its...

Continue Reading
Investing in Class Actions: What Shareholders Need to Know

Updated Category News Views 234

Understanding Class Action Lawsuits for Investors With the increasing complexities of the stock market, investors must stay informed about their rights and the challenges they may face. Class action lawsuits arise when a group of investors suffer losses due to misstatements or fraud by a company. Recently, three companies, Metagenomi, AMMO, and Paragon 28, are under...

Continue Reading
David Samuelson Takes on Leadership Role at Alliance for Decision Education

Updated Category News Views 286

Exciting Leadership Changes within the Alliance for Decision Education David Samuelson, a notable figure in education technology, has been appointed as the Executive Director of the Alliance for Decision Education. This organization is committed to enhancing decision-making education across schools nationwide. Samuelson brings a wealth of expertise, having served in...

Continue Reading
Anticipation Builds as Strawberry Fields REIT Prepares to Report Earnings

Updated Category News Views 125

Overview of Strawberry Fields REIT Earnings Expectations Strawberry Fields REIT (NASDAQ: STRW) is preparing to announce its quarterly earnings shortly. Investors are eager to know what the company will reveal regarding its financial performance. The anticipation is high as expectations build within the market. Analyst Expectations for Earnings Performance Financial...

Continue Reading
Pomerantz Investigates Securities Claims for Investors of PSN

Updated Category News Views 172

Pomerantz LLP's Investigation into Parsons Corporation Pomerantz LLP has initiated an investigation concerning claims made on behalf of investors of Parsons Corporation (NYSE: PSN). This inquiry is focused on whether the Company, including its officers or directors, might have participated in unlawful business practices, including securities fraud. Concerns About...

Continue Reading